Welcome to Artimmune - Your trusted partner in drug discovery for inflammation and infection. With a focus on scientific expertise, collaboration, and reliability, we are dedicated to advancing research in immunology and inflammation. As the world faces the challenges of COVID-19, Artimmune is committed to providing optimized research solutions. Our murine model of cytokine storm aids in the investigation of new drug candidates to combat COVID-19. Explore our preclinical CRO services and benefit from our extensive experience in lung diseases and immunology. Contact us to drive your research projects forward.
Our services
In vivo
Artimmune provides preclinical in vivo and ex vivo CRO services with more than 10 years of expertise in evaluating the efficacy of drug candidates in inflammation, autoimmunity and infection. We also offer our scientific expertise to help our clients design and run efficient and cost-effective studies in rodents.
-
Acute Lung Inflammation (ALI)
- LPS induced
-
Arthritis
- KBxN induced in mice
- Collagen type II antigen
-
Asthma
- House dust mite (HDM) induced in mice
- OVA induced in mice
- Papain induced in mice
- Birch pollen induced in mice
-
Autoimmunity
- Immune thrombocytopenic purpura (ITP)
- Multiple sclerosis
-
COPD
- Cigarette smoke
- Ozone
- Elastase
-
Cytokine storm
- In vivo anti CD3e
-
Fibrosis
- Bleomycin induced in mice and rats
- CCL4 induced in mice
- Silica induced in mice
-
Infection (in rehabilitation)
- Influenza A virus
- Pseudomonas aeruginosa
-
Inflammatory Bowel Disease
- DSS induced
- TNBS induced
-
Peritonitis
- Zymosan induced in mice
- LPS induced in mice
-
Skin inflammation
- Psoriasis (Imiquimod)
- Wound healing
- Atopic dermatitis
- Prurit